| Impact of social determinants of health on the emerging COVID-19 pandemic in the United States S Singu, A Acharya, K Challagundla, SN Byrareddy Frontiers in public health 8, 406, 2020 | 473 | 2020 |
| Exosome-mediated transfer of microRNAs within the tumor microenvironment and neuroblastoma resistance to chemotherapy KB Challagundla, PM Wise, P Neviani, H Chava, M Murtadha, T Xu, ... Journal of the National Cancer Institute 107 (7), djv135, 2015 | 416 | 2015 |
| Long non-coding RNAs are emerging targets of phytochemicals for cancer and other chronic diseases S Mishra, SS Verma, V Rai, N Awasthee, S Chava, KM Hui, AP Kumar, ... Cellular and Molecular Life Sciences 76 (10), 1947-1966, 2019 | 240 | 2019 |
| Positive regulation of p53 stability and activity by the deubiquitinating enzyme Otubain 1 XX Sun, KB Challagundla, MS Dai The EMBO Journal 31 (3), 576-592, 2012 | 228 | 2012 |
| miR‐15a‐5p, miR‐15b‐5p, and miR‐16‐5p inhibit tumor progression by directly targeting MYCN in neuroblastoma S Chava, CP Reynolds, AS Pathania, S Gorantla, LY Poluektova, ... Molecular oncology 14 (1), 180-196, 2020 | 140 | 2020 |
| Long non-coding RNAs and nuclear factor-κB crosstalk in cancer and other human diseases SC Gupta, N Awasthee, V Rai, S Chava, V Gunda, KB Challagundla Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1873 (1), 188316, 2020 | 136 | 2020 |
| COVID-19 and Cancer Comorbidity: Therapeutic Opportunities and Challenges AS Pathania, P Prathipati, BAA Abdul, S Chava, SS Katta, SC Gupta, ... THERANOSTICS 11 (2), 731-753, 2021 | 125 | 2021 |
| Ribosomal protein L11 recruits miR-24/miRISC to repress c-Myc expression in response to ribosomal stress KB Challagundla, XX Sun, X Zhang, T DeVine, Q Zhang, RC Sears, ... Molecular and cellular biology 31 (19), 4007-4021, 2011 | 124 | 2011 |
| Interplay between ribosomal protein S27a and MDM2 protein in p53 activation in response to ribosomal stress XX Sun, T DeVine, KB Challagundla, MS Dai Journal of Biological Chemistry 286 (26), 22730-22741, 2011 | 120 | 2011 |
| PD-L1, inflammation, non-coding RNAs, and neuroblastoma: Immuno-oncology perspective P Nallasamy, S Chava, SS Verma, S Mishra, S Gorantla, DW Coulter, ... Seminars in cancer biology 52, 53-65, 2018 | 86 | 2018 |
| HIV induces TRAIL sensitivity in hepatocytes CK Babu, K Suwansrinon, GD Bren, AD Badley, SA Rizza PLoS One 4 (2), e4623, 2009 | 83 | 2009 |
| SARS-CoV-2 infection and oral health: therapeutic opportunities and challenges CJ Coke, B Davison, N Fields, J Fletcher, J Rollings, L Roberson, ... Journal of Clinical Medicine 10 (1), 156, 2021 | 73 | 2021 |
| New insights into exosome mediated tumor-immune escape: Clinical perspectives and therapeutic strategies AS Pathania, P Prathipati, KB Challagundla Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1876 (2), 188624, 2021 | 71 | 2021 |
| Oxidative damage of plasma proteins and lipids in epidemic dropsy patients: Alterations in antioxidant status M Das, K Babu, NP Reddy, LM Srivastava Biochimica et Biophysica Acta (BBA)-General Subjects 1722 (2), 209-217, 2005 | 71 | 2005 |
| Exosomal long non-coding RNAs: Emerging players in the tumor microenvironment AS Pathania, KB Challagundla Molecular Therapy-Nucleic Acids, 2021 | 69 | 2021 |
| Targeting IκappaB kinases for cancer therapy N Awasthee, V Rai, S Chava, P Nallasamy, AB Kunnumakkara, ... Seminars in cancer biology 56, 12-24, 2019 | 65 | 2019 |
| MicroRNAs in the Tumor Microenvironment: solving the riddle for a better Diagnostics KB Challagundla, F Fanini, I Vannini, P Wise, M Murtadha, L Malinconico, ... Expert Review of Molecular Diagnostics 14 (5), 565-574, 2014 | 62 | 2014 |
| Kaposi’s Sarcoma-associated Herpesvirus microRNAs in Sepsis and Surgical Trauma CGA Tudor S, Giza DE, Lin HY, Fabris L, Yoshiaki K D’Abundo L, Toale KM ... Cell Death Disease 5, e1559, 2014 | 61* | 2014 |
| Serum miR-29a is upregulated in acute graft-versus-host disease and activates dendritic cells through TLR binding P Ranganathan, A Ngankeu, NC Zitzer, PP Leoncini, X Yu, L Casadei, ... The Journal of Immunology 198 (6), 2500-2512, 2017 | 59 | 2017 |
| Old drugs, new uses: Drug repurposing in hematological malignancies VP Kale, H Habib, R Chitren, M Patel, KC Pramanik, SC Jonnalagadda, ... Seminars in cancer biology 68, 242-248, 2021 | 56 | 2021 |
Tiffany DeVineOregon Health Science UniversityVerified email at ohsu.edu
